Package Leaflet: Information for the User
Zaditen 0.25mg/ml eye drops solution
Ketotifen
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.,Keep this leaflet. You may need to read it again.
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack:
Zaditen contains the active substance ketotifen, which is an antiallergic substance. Zaditen is used to treat the ocular symptoms of seasonal allergic conjunctivitis.
You should consult a doctor if it worsens or does not improve.
Do not use Zaditen
If you are allergic (hypersensitive) to ketotifen or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start using Zaditen.
Using Zaditen with other medicines
If you need to apply any other eye medicine besides Zaditen, wait at least 5 minutes between applying each product.
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. This is especially important with medicines used to treat:
Using Zaditen with food, drinks, and alcohol
Zaditen may increase the effects of alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Zaditen can be used during breastfeeding.
Driving and using machines
Zaditen may cause blurred vision or drowsiness. Do not drive or use machines until these effects have gone.
Zaditen contains benzalkonium chloride.
This medicine contains 2.6 micrograms of benzalkonium chloride in each drop.
Benzalkonium chloride may be absorbed by soft contact lenses and may alter the color of the contact lenses. Remove contact lenses before using this medicine and wait 15 minutes before putting them back.
Benzalkonium chloride may cause eye irritation, especially if you have dry eyes or other corneal diseases (the transparent layer on the front of the eye). Talk to your doctor if you feel any unusual sensation, itching, or pain in the eye after using this medicine.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again if you have any doubts.
The recommended dose in adults, the elderly, and children (3 years or older) is one drop in the affected eye(s) twice a day (morning and evening).
Instructions for use
Fig. 1 Fig. 2 Fig. 3
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
If you use more Zaditen than you should
There is no danger if you accidentally take Zaditen orally, nor if more than one drop accidentally falls into your eye. If in doubt, consult your doctor. Also, in case of overdose or accidental ingestion, you can consult the Toxicology Information Service Tel.: 91 562 04 20.
If you forget to use Zaditen
If you forget to use Zaditen, apply the treatment as soon as you remember. Then, go back to your regular treatment schedule.
Do not take a double dose to make up for forgotten doses.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported.
Common(affects less than 1 in 10patients)
Uncommon(affects less than1 in 100 patients)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not store above 25°C.
The bottle itself is not sterile, but its contents are sterile until the bottle is opened.
After the first opening of the bottle, the eye drops can only be stored for 4 weeks.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Zaditen composition
The active substance is ketotifen (as fumarate). Each ml contains 0.345 mg of ketotifen fumarate, which corresponds to 0.25 mg of ketotifen.
The other ingredients are glycerol (E422), sodium hydroxide (E524), water for injections, and benzalkonium chloride.
Appearance and pack contents
Zaditen is a clear, colorless to pale yellow solution. The solution is presented in a pack containing a 5 ml bottle.
Marketing authorization holder
Laboratoires THEA – 12, rue Louis Blériot – 63017 Clermont-Ferrand Cedex 2 – France
Manufacturer
EXCELVISION – 27 rue de la Lombardière – 07100 Annonay - France.
Local representative
Laboratorios THEA S.A. – Pg. Sant Joan 91, 08009 Barcelona
This medicine is authorized in the Member States of the European Economic Area under the following names:
Austria Zaditen 0,025% - Augentropfen
Denmark Zaditen
Finland Zaditen 0,25 mg/ml silmätipat, liuos
France Zalergonium, 0,25 mg/ml, collyre en solution
Germany Zaditen ophtha 0,25 mg/ml Augentropfen
Greece Zaditor οφθαλμικές σταγόνες
Iceland Zaditen
Ireland Zaditen 0.25mg/ml, eye drops, solution
Luxembourg Zaditen 0,25 mg/ml, collyre en solution
Norway Zaditen
Portugal Zaditen 0,25 mg/ml colírio, solução
Spain Zaditen 0,25 mg/ml colirio en solución
Sweden Zaditen 0,25 mg/ml, ögondroppar, lösning
Netherlands Zaditen 0,25 mg/ml, oogdruppels, oplossing
United Kingdom Zaditen 0.25 mg/ml, eye drops, solution
Date of last revision of this leaflet:10/2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/